Introduction
Tom Aspinall has unexpectedly vacated the UFC heavyweight championship, citing persistent eye issues that prevent medical clearance. The British fighter's decision sends shockwaves through the MMA community and forces the promotion to act quickly in the stacked heavyweight division.
What Happened
The vacancy follows Aspinall's October 2025 UFC 321 main event against Ciryl Gane, which ended in a no-contest after a controversial eye poke. Subsequent diagnosis revealed traumatic bilateral Brown's syndrome, requiring surgical intervention on both eyes. Despite extensive rehabilitation, ongoing complications have prevented medical clearance for competition.
Why This Matters
Aspinall's title vacancy reshapes the UFC heavyweight landscape at a critical juncture. With the championship now open, the promotion must decide whether to elevate Ciryl Gane to undisputed status or initiate a new contender tournament. The situation underscores the primacy of athlete health in combat sports and impacts the division's immediate future.
Key Takeaways
- Aspinall vacates the UFC heavyweight championship due to unresolved eye complications
- His final fight versus Gane concluded in a no-contest after a foul-induced eye injury
- He received a diagnosis of bilateral Brown's syndrome and underwent multiple eye surgeries
- The UFC now faces the task of reconfiguring the heavyweight title picture
- Aspinall maintains he has not retired from the sport and will pursue recovery
- Matchroom's Eddie Hearn has publicly expressed support for Aspinall's return timeline
Conclusion
Aspinall's unexpected title departure highlights the fragile nature of combat sports careers, where health always takes precedence. While fans anticipate his potential return, the UFC must act swiftly to fill the void in the heavyweight division. Regardless of the outcome, Aspinall's commitment to recovery suggests he will compete again when medically able.




Discussion
Join the conversation
Thoughtful reactions, questions, and follow-up ideas help shape the next story.